These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 19919608)
1. Solid organ transplantation in survivors of hematopoietic cell transplantation: a single institution case series and literature review. Beitinjaneh A; Burns LJ; Majhail NS Clin Transplant; 2010; 24(4):E94-102. PubMed ID: 19919608 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation after Solid Organ Transplantation. Doney KC; Mielcarek M; Stewart FM; Appelbaum FR Biol Blood Marrow Transplant; 2015 Dec; 21(12):2123-2128. PubMed ID: 26271193 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Cell and Solid Organ Transplantation in the Same Patient: Long-Term Experience at the University of Minnesota. El Jurdi N; DeFor T; Adamusiak AM; Brunstein CG; Pruett T; Weisdorf DJ Transplant Cell Ther; 2021 Jan; 27(1):87.e1-87.e6. PubMed ID: 32949755 [TBL] [Abstract][Full Text] [Related]
5. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641 [TBL] [Abstract][Full Text] [Related]
6. A single center experience of combined liver kidney transplantation. Mehrabi A; Fonouni H; Ayoub E; Rahbari NN; Müller SA; Morath Ch; Seckinger J; Sadeghi M; Golriz M; Esmaeilzadeh M; Hillebrand N; Weitz J; Zeier M; Büchler MW; Schmidt J; Schmied BM Clin Transplant; 2009 Dec; 23 Suppl 21():102-14. PubMed ID: 19930323 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic stem-cell transplantation following solid-organ transplantation in children. Schechter T; Gassas A; Weitzman S; Grant D; Pollock-BarZiv S; Dipchand A; Alexander S; Ali M; Avitzur Y; Doyle J Bone Marrow Transplant; 2011 Oct; 46(10):1321-5. PubMed ID: 21822316 [TBL] [Abstract][Full Text] [Related]
8. Solid organ transplants following hematopoietic stem cell transplant in children. Bunin N; Guzikowski V; Rand ER; Goldfarb S; Baluarte J; Meyers K; Olthoff KM Pediatr Transplant; 2010 Dec; 14(8):1030-5. PubMed ID: 20846242 [TBL] [Abstract][Full Text] [Related]
9. Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature. Brockmann JG; Broering DC; Raza SM; Rasheed W; Hashmi SK; Chaudhri N; Nizami IY; Alburaiki JAH; Shagrani MA; Ali T; Aljurf M Bone Marrow Transplant; 2019 Feb; 54(2):190-203. PubMed ID: 30082851 [TBL] [Abstract][Full Text] [Related]
10. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
11. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Kopp M; Holzner B; Meraner V; Sperner-Unterweger B; Kemmler G; Nguyen-Van-Tam DP; Nachbaur D Eur J Haematol; 2005 Apr; 74(4):304-8. PubMed ID: 15777342 [TBL] [Abstract][Full Text] [Related]
12. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723 [TBL] [Abstract][Full Text] [Related]
14. Should we be performing more combined hematopoietic stem cell plus solid organ transplants? Chiang KY; Lazarus HM Bone Marrow Transplant; 2003 Apr; 31(8):633-42. PubMed ID: 12692602 [TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC. Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807 [TBL] [Abstract][Full Text] [Related]
17. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. Syrjala KL; Langer SL; Abrams JR; Storer BE; Martin PJ J Clin Oncol; 2005 Sep; 23(27):6596-606. PubMed ID: 16170167 [TBL] [Abstract][Full Text] [Related]
18. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study. Shankar SM; Carter A; Sun CL; Francisco L; Baker KS; Gurney JG; Weisdorf DG; Forman SJ; Robison LL; Grant M; Bhatia S Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):834-9. PubMed ID: 17416780 [TBL] [Abstract][Full Text] [Related]
19. The natural history of renal function following orthotopic heart transplant. Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562 [TBL] [Abstract][Full Text] [Related]